Speaker Profile
Kenneth S. Ramos

Kenneth S. Ramos MD, PhD, PharmB

Genetics, Medical Toxicology
Phoenix, Arizona, United States of America

Connect with the speaker?

Kenneth S. Ramos, MD, Ph.D., PharmD, served as associate vice president for precision health sciences at the University of Arizona Health Sciences, director of the Center for Applied Genetics and Genomic Medicine and the MD-PhD Program, and professor of medicine. In 2019, Dr. Ramos accepted a position as executive director of the Institute of Biosciences and Technology in Houston and assistant vice chancellor for Health Services at The Texas A&M University System.

Dr. Ramos is a physician-scientist with interests in molecular and precision medicine, particularly as it relates to vascular pathology, oncology, and chronic diseases of the lung. His translational research program integrates diverse approaches ranging from molecular genetics to population-based studies to elucidate genetic and genomic mechanisms of pathogenesis and to develop novel approaches and therapies to minimize chronic diseases caused by environmental injury. Ongoing translational studies in his laboratory focus on the study of repetitive genetic elements in the mammalian genome and their role in genome plasticity, toxicity, and disease, while clinical studies focus on the development and characterization of diagnostic and prognostic biomarkers of cancer and chronic pulmonary disease to advance the goals of personalized genomic medicine.

Dr. Ramos has directed two NIH P30 Centers of Excellence working at the interface between genomics and environmental health and medicine and has provided the administrative and scientific leadership for two academic centers focusing on genetics and genomic medicine. He has influenced the career of many scientists through my involvement in several NIH-funded training and career development programs where he has mentored over 100 doctoral, medical, veterinary, undergraduate, and high school students, many of whom have gone on to successful careers in academia, medicine, government, and industry. He is deeply committed to initiatives that advance precision medicine and its applications to reduce disease burden and health disparities, improve the quality of healthcare and reduce costs.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)